glycerol has been researched along with Catarrh in 6 studies
Moon: The natural satellite of the planet Earth. It includes the lunar cycles or phases, the lunar month, lunar landscapes, geography, and soil.
Catarrh: Inflammation of a mucous membrane with increased flow of mucous in humans or animals. Catarrh is used mostly in a historical context.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A glycerol throat spray containing cold-adapted cod trypsin (GCTS) deactivates common cold virus in vitro and decreases pharyngeal rhinovirus load after inoculation in humans." | 9.51 | Early intervention with a glycerol throat spray containing cold-adapted cod trypsin after self-diagnosis of common cold: A randomised trial. ( Lindberg, F; Nelson, I; Ranstam, J; Riker, DK, 2022) |
| "Previous clinical and in vitro investigations have supported the efficacy of a glycerol throat spray containing cold-adapted cod trypsin (ColdZyme) against respiratory viruses causing the common cold bycreating a protective mucosal barrier shown to deactivate common cold virus in vitro and decrease pharyngeal rhinovirus load." | 5.69 | Early intervention with ColdZyme mouth spray after self-diagnosis of common cold: A randomized, double-blind, placebo-controlled study. ( Lindberg, BF; Nelson, I; Ranstam, J; Riker, DK, 2023) |
| "A glycerol throat spray containing cold-adapted cod trypsin (GCTS) deactivates common cold virus in vitro and decreases pharyngeal rhinovirus load after inoculation in humans." | 5.51 | Early intervention with a glycerol throat spray containing cold-adapted cod trypsin after self-diagnosis of common cold: A randomised trial. ( Lindberg, F; Nelson, I; Ranstam, J; Riker, DK, 2022) |
| "Prior influenza vaccination had no effect on study outcome." | 2.84 | Randomized, double-blind, placebo-controlled clinical trial to assess the safety and effectiveness of a novel dual-action oral topical formulation against upper respiratory infections. ( Adkins, I; Arters, K; Buchheit, K; Esper, F; Ghannoum, MA; Mukherjee, PK; Salata, RA, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 4 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Lindberg, F | 2 |
| Nelson, I | 2 |
| Ranstam, J | 2 |
| Riker, DK | 2 |
| Lindberg, BF | 1 |
| Davison, G | 1 |
| Perkins, E | 1 |
| Jones, AW | 1 |
| Swart, GM | 1 |
| Jenkins, AR | 1 |
| Robinson, H | 1 |
| Dargan, K | 1 |
| Gudmundsdottir, Á | 1 |
| Scheving, R | 1 |
| Stefansson, B | 1 |
| Mukherjee, PK | 1 |
| Esper, F | 1 |
| Buchheit, K | 1 |
| Arters, K | 1 |
| Adkins, I | 1 |
| Ghannoum, MA | 1 |
| Salata, RA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Pilot Study of the Safety, Tolerability, and Effectiveness of Halo to Prevent Acute Upper Respiratory Disease and Respiratory Virus Infections[NCT02644135] | 100 participants (Actual) | Interventional | 2013-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Measured by medical record review. (NCT02644135)
Timeframe: Through study duration, an average of 3 months
| Intervention | Number of acute respiratory illnesses (Number) |
|---|---|
| Halo Oral Spray | 4 |
| Halo Placebo | 2 |
(NCT02644135)
Timeframe: Through study duration, an average of 3 months
| Intervention | participants (Number) |
|---|---|
| Halo Oral Spray | 2 |
| Halo Placebo | 4 |
4 trials available for glycerol and Catarrh
| Article | Year |
|---|---|
Early intervention with a glycerol throat spray containing cold-adapted cod trypsin after self-diagnosis of common cold: A randomised trial.
Topics: Adult; Common Cold; Glycerol; Humans; Pharynx; Prospective Studies; Quality of Life; Rhinovirus; Sev | 2022 |
Early intervention with ColdZyme mouth spray after self-diagnosis of common cold: A randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Common Cold; Double-Blind Method; Female; Glycerol; Humans; Male; Middle Ag | 2023 |
Coldzyme® Mouth Spray reduces duration of upper respiratory tract infection symptoms in endurance athletes under free living conditions.
Topics: Adult; Antiviral Agents; Athletes; Athletic Performance; Bicycling; Common Cold; Drug Administration | 2021 |
Randomized, double-blind, placebo-controlled clinical trial to assess the safety and effectiveness of a novel dual-action oral topical formulation against upper respiratory infections.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Anti-Infective Agents, Local; Cety | 2017 |
2 other studies available for glycerol and Catarrh
| Article | Year |
|---|---|
Inactivation of SARS-CoV-2 and HCoV-229E in vitro by ColdZyme® a medical device mouth spray against the common cold.
Topics: Antiviral Agents; Common Cold; Coronavirus 229E, Human; COVID-19; COVID-19 Drug Treatment; Disinfect | 2021 |
Best drugs for what ails you: the brands to buy--and those to skip.
Topics: Acetaminophen; Anesthetics, Local; Cetirizine; Chlorpheniramine; Common Cold; Cough; Dextromethorpha | 2009 |